It’s official. Consumer Reports’ engineers have just completed testing the iPhone 4, and have confirmed that there is a problem with its reception. When your finger or hand touches a spot on the phone’s lower left side—an easy thing, especially for lefties—the signal can significantly degrade enough to cause you to lose your connection altogether if you’re in an area with a weak signal. Due to this problem, we can’t recommend the iPhone 4.
That’s Consumer Reports, incidentally, which put the phone in an RF-isolated room to perform their tests along with a base-station emulator.
Oops – that’s about as close to proof as you’re going to find. In an RF-quiet environment it’s pretty easy to prove your case, and it appears that CR did so.
The tests also indicate that AT&T’s network might not be the primary suspect in the iPhone 4′s much-reported signal woes.
I have never been impressed with the iPhone (any generation) in terms of RF. Ever. It has always been a "form before function" device from my perspective, all the way back to the original units. Then again I’m spoiled – the best RF-performing GSM phone I’ve ever used was a Nokia 3395. I may still have one laying around here somewhere, and all of my old Nokias (including a 6610 which was nearly as good) still work just fine. Old, yes, but one thing Nokia does know how to do is design and build an RF section.
Incidentally, buying devices that work before selecting them for "sex appeal" may be why I’ve never had a material problem with the "can you hear me?" BS that so many suffer with when it comes to cellphones. I guess my view is that a cellphone is for communicating rather than trying to shag some hot chick at the local bar by flashing my "bling."
This is a common flaw for consumer devices – be sexy rather than be smart – or good. Of course sex sells, and so the more "sexy" you can make something look the better it sells, and as long as you remain within the "acceptable" functionality envelope you don’t get hurt – too badly. Witness Motorola, which had the "hot" phone for a long time…
Apple has had a hell of a time with what is arguably its most important product release since the initial iPhone in 2007. The handsets have been plagued with spotty screens, combustible USB ports, signal strength measurement inconsistencies, and the most damaging of the issues – an ill-conceived antenna design that causes attenuation when held from the lower left had corner. Steve Jobs did the Blankfein (Goldman Sachs CEO, stating that the Wall Street bank was doing God’s work) imitation by opening his mouth when he shouldn’t have and said that users were “hold the phone the wrong way”. Not only that, but Consumer Reports just came out with a report stating that they can not recommend the buying of an iPhone until the antenna situation has been rectified, prompting speculation that Apple will be forced to recall millions of phones.
As a matter of fact, the review was rather poignant:
“If you want an iPhone that works well without a masking-tape fix, we continue to recommend an older model, the 3G S.”
One solution to the Apple iPhone 4’s antenna problem is to cover the lower left corner with tape.
It is very easy to fall out of favor with the trendy crowd. While I doubt very seriously that Apple is in danger of doing this anytime soon, a massive recall will open the door for devices which are technically much more capable, flexible and open than the iPhone, ex. the Android powered HTC and Samsung devices. Basically, the danger to Apple here is not the expense of a recall, but the loss of mindshare and potential widening of the opening for some very capable competition – an opening that did not have to be there!
Don’t believe me, click the link to the consumer reports article and peruse the comment section…
The central issue in the U.S. Presidential campaign can’t even be discussed in U.S. newsmedia, because America’s media have been almost uniformly complicit all along in hiding from the American public the crucial factual information that’s necessary in order for the public to vote in an intelligent and truthfully informed way about it. No news medium wants to report its own having been complicit in anything; so...
Our benchmark S&P 500 continued in its range-bound sideways trend, posting a fractional gain of 0.16% that essentially split the different between the intraday high and low. The small gain extended the fractional up-down pattern of daily closes to eleven sessions. Meanwhile, West Texas Intermediate Crude fell 1.86% today and is now in bear territory, down 20.16% from its interim high 36 sessions ago on June 8th.
The yield on the 10-year remined unchanged at 1.52%.
Here is a snapshot of past five sessions in the S&P 500.
Here is a daily chart of the index. We've highlighted the unusually narrow pattern over the past eleven sessions, both in closes and intraday trading ranges. To repeat again the pervading question: Wil...
By Jacob Wolinsky. Originally published at ValueWalk.
NetSuite Inc (NYSE:N) is soaring this morning as Oracle Corporation (NASDAQ:ORCL) has made a bid to buy the company for $9.3 billion. This deal has been rumored for some time but obviously few expected such a large premium or did not think the bid was certaintly coming as the stock is up about 18 percent at the time of this writing which is a lot for a tech giant. Here is what the sell side is saying.
NetSuite – analysts react
Should the transaction take place, Oracle would pay about 9x NTM EV / revenue (based on consensus estimates for NetSuite), above the average multiple paid in our precedent SaaS Software acquisitions analysis of 6.8x . Additionally, Oracl...
The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday July 27, 2016:
Sequenom Being Acquired by Lab Corp for $2.40/Share in Cash
Laboratory Corporation of America Holdings (NYSE: LH) and Sequenom, Inc. (NASDAQ: SQNM) announced Wednesday, that they have entered into a definitive agreement aunder which LabCorp would acquire all of the outstanding shares of Sequenom in a cash tender offer for $2.40 per share, for an equity value of $302 million.
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here
After a three-year bull run that more than quadrupled its value by its peak last July, IBD’s Medical-Biomed/Biotech Industry Group plunged 50% by early February, hurt by backlashes against high drug prices and mergers that seek to lower corporate taxes.
This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible. Feel free to contact me directly at firstname.lastname@example.org with any questions.
Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts. After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.) Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.
Note: The material presented in this commentary is provided for
informational purposes only and is based upon information that is
considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW)
nor its affiliates
warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
Site owned and operated by PSW Investments, LLC. Contact us at: 403 Central Avenue, Hawthorne, NJ 07506. Phone: (201) 743-8009. Email: email@example.com.